Schedule 13D ownership disclosure
SORRENTO THERAPEUTICS IN
Security class unavailable · CUSIP: 83587F202
Event date: 2017-07-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,397,853
- Percent of class
- 1.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-044160
- Form type
- SC 13D
- Filer
- Ally Bridge Group Capital Partners II, L.P.
- CIK
- CIK 1609313
- Filed
- Jul 10, 2017
- Reporting period
- Jul 10, 2017
- Description
- Schedule 13D beneficial ownership